Strain Elastography Fat-to-Lesion Index Is Associated with Mammography BI-RADS Grading, Biopsy, and Molecular Phenotype in Breast Cancer
Biosensors · 2024
DOI: 10.3390/bios14020094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2024. Verfasst von José Alfonso Cruz-Ramos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Clínicas Médicas, Instituto de Patología Infecciosa y Experimental, Centro Universitario de Ciencias de la Salud, Universidad de Guad…. Hauptthemen laut MEDLINE: Breast Neoplasms, Elasticity Imaging Techniques, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conacyt Fossis.
Abstract (Originalsprache)
Breast cancer (BC) affects millions of women worldwide, causing over 500,000 deaths annually. It is the leading cause of cancer mortality in women, with 70% of deaths occurring in developing countries. Elastography, which evaluates tissue stiffness, is a promising real-time minimally invasive technique for BC diagnosis. This study assessed strain elastography (SE) and the fat-to-lesion (F/L) index for BC diagnosis. This prospective study included 216 women who underwent SE, ultrasound, mammography, and breast biopsy (108 malignant, 108 benign). Three expert radiologists performed imaging and biopsies. Mean F/L index was 3.70 ± 2.57 for benign biopsies and 18.10 ± 17.01 for malignant. We developed two predictive models: a logistic regression model with AUC 0.893, 79.63% sensitivity, 87.62% specificity, 86.9% positive predictive value (+PV), and 80.7% negative predictive value (−PV); and a neural network with AUC 0.902, 80.56% sensitivity, 88.57% specificity, 87.9% +PV, and 81.6% −PV. The optimal Youden F/L index cutoff was >5.76, with 84.26% sensitivity and specificity. The F/L index positively correlated with BI-RADS (Spearman’s r = 0.073, p < 0.001) and differed among molecular subtypes (Kruskal-Wallis, p = 0.002). SE complements mammography for BC diagnosis. With adequate predictive capacity, SE is fast, minimally invasive, and useful when mammography is contraindicated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Clínicas Médicas, Instituto de Patología Infecciosa y Experimental, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara; Guadalajara 44340, Mexico.
- Subdirección de Desarrollo Institucional, Instituto Jalisciense de Cancerología, Guadalajara 44280, Mexico.
- Departamento de Ciencias Computacionales, Instituto Nacional de Astrofísica Óptica y Electrónica, San Andrés Cholula 72840, Mexico.
- Laboratorio de Biomédica-Mecatrónica, Subdirección de Investigación y Extensión, Centro de Enseñanza Técnica Industrial Plantel Colomos, Guadalajara 44638, Mexico.
ORCID-Profile: José Alfonso Cruz-Ramos, Gabriela Del Carmen López-Armas
Förderung
- Conacyt Fossis
Zitieren
APA
Cruz-Ramos, J. A., Trapero-Corona, M. I., Valencia-Hernández, I. A., Gómez-Vargas, L. A., Toranzo-Delgado, M. T., Cano-Magaña, K. R., De la Mora-Jiménez, E., & Del Carmen López-Armas, G. (2024). Strain Elastography Fat-to-Lesion Index Is Associated with Mammography BI-RADS Grading, Biopsy, and Molecular Phenotype in Breast Cancer. Biosensors. https://doi.org/10.3390/bios14020094
Vancouver
Cruz-Ramos JA, Trapero-Corona MI, Valencia-Hernández IA, Gómez-Vargas LA, Toranzo-Delgado MT, Cano-Magaña KR, et al. Strain Elastography Fat-to-Lesion Index Is Associated with Mammography BI-RADS Grading, Biopsy, and Molecular Phenotype in Breast Cancer. Biosensors. 2024. doi:10.3390/bios14020094
BibTeX
@article{CruzRamos2024,
author = {Cruz-Ramos, José Alfonso and Trapero-Corona, Mijaíl Irak and Valencia-Hernández, Ingrid Aurora and Gómez-Vargas, Luz Amparo and Toranzo-Delgado, María Teresa and Cano-Magaña, Karla Raquel and De la Mora-Jiménez, Emmanuel and Del Carmen López-Armas, Gabriela},
title = {Strain Elastography Fat-to-Lesion Index Is Associated with Mammography BI-RADS Grading, Biopsy, and Molecular Phenotype in Breast Cancer},
journal = {Biosensors},
year = {2024},
doi = {10.3390/bios14020094}
}
EUVIMED